The Augmented MSL
This week's guest is Nandini Sabharwal, Director, Migraine and Women's Health, Field Medical Group at Pfizer and we discuss the role of artificial intelligence in every day MSL life.
Key Points
- Embracing AI can significantly reduce preparation time for MSLs by providing quick, insightful answers and aiding in role-specific tasks such as healthcare provider meeting prep and advisory board planning.
- Effective use of generative AI tools like ChatGPT or Microsoft Copilot requires learning how to craft detailed, specific prompts and understanding the limitations of these tools, including the necessity of refining the output manually.
- Company buy-in and licensing are crucial for integrating AI tools into daily workflows, and while the initial learning curve can be steep, the productivity gains and potential for improved communication make it a worthwhile investment for MSLs.
This episode is sponsored by MSL Mastery, helping Medical Science Liaisons and aspiring MSLs to excel in their careers and lives through courses, coaching, and community. For more details, please visit MSLmastery.com
In this episode, Nandini shares…
👉 The learning process and getting started with AI 👉 How MSLs can upskill with AI tools 👉 What Prompt Engineering is and how to master the art of “prompts” 👉 The challenges to be aware of when adopting AI 👉 The many benefits of using AI and what the future holds
The MSL Talk Podcast is available on all podcast platforms and the MSL Talk YouTube Channel.
MSL Talk is a podcast that features helpful information for current Medical Science Liaisons, Medical Affairs leaders, job seekers looking to break into the pharmaceutical industry in their first MSL role as well as anyone interested in hearing good industry conversations and medical affairs discussions.
#msl #medicalaffairs #medicalscienceliaison #artificialintelligence #careers
Chapters
| 0:00 | |
| 1:45 | |
| 2:56 | |
| 4:20 | |
| 9:01 | |
| 12:52 | |
| 14:38 | |
| 18:22 | |
| 23:45 | |
| 26:12 | |
| 29:06 | |
| 30:24 | |
| 31:11 | |
| 32:33 |
Transcript
Loading transcript...